Publications by authors named "Giselle Singer"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

5,870

Total Likes

111

Extended Reach

73,574

Social Features

10
S
Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement.
Celina Dubin, Jacob W Glickman, Ester Del Duca, Sumanth Chennareddy, Joseph Han, Dante Dahabreh, Yeriel D Estrada, Ning Zhang, Grace W Kimmel, Giselle Singer

J Am Acad Dermatol· March 2022

Videos about Article: user user

2 8 3

View All Article and Social Media Activity
L
Large-Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles.
Jacob W Glickman, Eden David, Neda Shokrian, Kelly Hawkins, Ester Del Duca, Giselle Singer

Allergy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2a trial of brepocitinib for cicatricial alopecia.
Eden David, Neda Shokrian, Ester Del Duca, Marguerite Meariman, Celina Dubin, Giselle Singer

J Am Acad Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone.
Dina Poplausky, Jade N Young, Brandon R Block, Yeriel Estrada, Giselle K Singer

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab responses vary across the spectrum of congenital ichthyosis in adults.
Rachel Lefferdink, Stephanie M Rangel, Margot Chima, Erin Ibler, Ana B Pavel, Giselle Singer

Arch Dermatol Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, John Nia, Peter Hashim, Giselle K Singer

Arch Dermatol Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI.
Hee J Kim, Ester Del Duca, Ana B Pavel, Giselle K Singer, Brian J Abittan

Arch Dermatol Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients.
Benjamin Ungar, Susan Hartzell, Daniel Lozano-Ojalvo, Sabrina Ghalili, Swaroop Bose, Giselle K Singer

Allergy· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.
Yael Renert-Yuval, Joel Correa da Rosa, Sandra Garcet, Ana B Pavel, Jennifer Bares, Giselle K Singer

Br J Dermatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis.
Benjamin Ungar, Leore Lavin, Alexandra K Golant, Alyssa Gontzes, Eden David, Giselle K Singer

Ann Allergy Asthma Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Emma Guttman-Yassky, Yael Renert-Yuval, Jennifer Bares, Margot Chima, Jason E Hawkes, Giselle K Singer

Allergy· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.
Benjamin Ungar, Jacob W Glickman, Alexandra K Golant, Celina Dubin, Olga Marushchak, Giselle K Singer

J Allergy Clin Immunol Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot study.
Hee J Kim, Giselle K Singer, Ester Del Duca, Brian J Abittan, Margot A Chima

J Am Acad Dermatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata.
Jacob W Glickman, Celina Dubin, Dante Dahabreh, Joseph Han, Ester Del Duca, Giselle Singer

Allergy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders.
Megan H Trager, Emanuelle Rizk, Sharon Rose, Kuixi Zhu, Branden Lau, Giselle Singer

Sci Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation.
Jacob W Glickman, Celina Dubin, Yael Renert-Yuval, Dante Dahabreh, Grace W Kimmel, Giselle Singer

J Am Acad Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis.
Benjamin Ungar, Ana B Pavel, Randall Li, Grace Kimmel, John Nia, Giselle K Singer

J Allergy Clin Immunol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial.
Peter W Hashim, Margot Chima, Hee J Kim, Jennifer Bares, Christopher J Yao, Giselle Singer

J Am Acad Dermatol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed.
Grace Kimmel, Margot Chima, Hee Jin Kim, Jennifer Bares, Christopher J Yao, Giselle Singer

J Am Acad Dermatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trial.
Sharon Rose, Shelbi Jim On, Wayne Fuchs, Chen Chen, Robert Phelps, Giselle Singer

J Am Acad Dermatol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
Patrick M Brunner, Ana B Pavel, Saakshi Khattri, Alexandra Leonard, Kunal Malik, Giselle K Singer

J Allergy Clin Immunol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata.
Daniela Mikhaylov, Ana Pavel, Christopher Yao, Grace Kimmel, John Nia, Giselle Singer

Arch Dermatol Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated model of alopecia areata biomarkers highlights both T1 and T2 upregulation.
Teresa Song, Ana B Pavel, Huei-Chi Wen, Kunal Malik, Yeriel Estrada, Giselle K Singer

J Allergy Clin Immunol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.
Emma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, Saakshi Khattri, Ana B Pavel, Giselle K Singer

J Am Acad Dermatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema.
Anjali Shroff, Dana Malajian, Tali Czarnowicki, Sharon Rose, Daniel M Bernstein, Giselle K Singer

Int J Dermatol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis